[1] |
Seccombe EL, Ardern-Jones M, Walker W, et al. Bronchiolitis obliterans as a long-term sequela of Stevens-Johnson syndrome and toxic epidermal necrolysis in children[J]. Clin Exp Dermatol, 2019, 44(8): 897-902.
doi: 10.1111/ced.13969
pmid: 30908698
|
[2] |
McPherson T, Exton LS, Biswas S, et al. British Association of Dermatologists' guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people, 2018[J]. Br J Dermatol, 2019, 181(1): 37-54.
doi: 10.1111/bjd.17841
pmid: 30829411
|
[3] |
Charlton OA, Harris V, Phan K, et al. Toxic epidermal necrolysis and Steven-Johnson syndrome: a comprehensive review[J]. Adv Wound Care (New Rochelle), 2020, 9(7): 426-439.
|
[4] |
Lee HY, Walsh SA, Creamer D. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up[J]. Br J Dermatol, 2017, 177(4): 924-935.
doi: 10.1111/bjd.15360
pmid: 28144971
|
[5] |
Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme[J]. Arch Dermatol, 1993, 129(1): 92-96.
pmid: 8420497
|
[6] |
Hsu DY, Brieva J, Silverberg NB, et al. Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States[J]. J Am Acad Dermatol, 2017, 76(5): 811-817.
doi: S0190-9622(16)31285-3
pmid: 28285784
|
[7] |
Antoon JW, Goldman JL, Lee B, et al. Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis[J]. Pediatr Dermatol, 2018, 35(2): 182-187.
doi: 10.1111/pde.13383
pmid: 29315761
|
[8] |
Kamada N, Kinoshita K, Togawa Y, et al. Chronic pulmonary complications associated with toxic epidermal necrolysis: report of a severe case with anti-Ro/SS-A and a review of the published work[J]. J Dermatol, 2006, 33(9): 616-622.
pmid: 16958806
|
[9] |
Xu N, Chen X, Wu S, et al. Chronic pulmonary complications associated with toxic epidermal necrolysis: a case report and literature review[J]. Exp Ther Med, 2018, 16(3):2027-2031.
doi: 10.3892/etm.2018.6357
pmid: 30186435
|
[10] |
Moonnumakal SP, Fan LL. Bronchiolitis obliterans in children[J]. Curr Opin Pediatr, 2008, 20(3): 272-278.
doi: 10.1097/MOP.0b013e3282ff62e9
pmid: 18475095
|
[11] |
Park H, Ko YB, Kwon HS, et al. Bronchiolitis obliterans associated with Stevens-Johnson syndrome: a case report[J]. Yonsei Med J, 2015, 56(2): 578-581.
doi: 10.3349/ymj.2015.56.2.578
pmid: 25684012
|
[12] |
Tanou K, Xaidara A, Kaditis AG. Efficacy of pulse methylprednisolone in a pediatric case of postinfectious bronchiolitis obliterans[J]. Pediatr Pulmonol, 2015, 50(5): E13-E16.
|
[13] |
Date H, Sano Y, Aoe M, et al. Living-donor lobar lung transplantation for bronchiolitis obliterans after Stevens-Johnson syndrome[J]. J Thorac Cardiovasc Surg, 2002, 123(2): 389-391.
|
[14] |
Shoji T, Bando T, Fujinaga T, et al. Living-donor single-lobe lung transplant in a 6-year-old girl after 7-month mechanical ventilator support[J]. J Thorac Cardiovasc Surg, 2010, 139(5): e112-e113.
|
[15] |
Zijtregtop EA, Pijnenburg MW, Rottier BL, et al. Bronchiolitis obliterans after Stevens-Johnson syndrome[J]. Ned Tijdschr Geneeskd, 2012, 156(19): A4387.
|
[16] |
Matar M, Kessler R, Olland A, et al. End-stage respiratory failure secondary to bronchiolitis obliterans syndrome induced by toxic epidermal necrosis, also known as Lyell syndrome: a case report[J]. Transplant Proc, 2021, 53(4): 1371-1374.
|
[17] |
YueB, Huang J, Jing L, et al. Bilateral lung transplantation for Castleman disease with end-stage bronchiolitis obliterans[J]. Clin Transplant, 2022, 36(1): e14496.
|
[18] |
Soubani AO, Kingah P, Alshabani K, et al. Lung transplantation following hematopoietic stem cell transplantation: report of two cases and systematic review of literature[J]. Clin Transplant, 2014, 28(7):776-782.
doi: 10.1111/ctr.12378
pmid: 24754643
|